Related Experiment Video
Updated: Oct 13, 2025
08:14
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
18.3K
Liquid Biopsy and Primary Brain Tumors
Robert H Eibl1, Markus Schneemann2
1c/o M. Schneemann, Department of Internal Medicine, Hospitals of Schaffhausen, 8208 Schaffhausen, Switzerland.
Cancers
|November 13, 2021
Summary
Liquid biopsy shows promise for brain tumor management but faces challenges. Further research is needed to establish biomarkers and standards for improved clinical application in cancer diagnosis and therapy.
Area of Science:
- Oncology
- Biochemistry
- Genetics
Background:
- Liquid biopsy offers a minimally invasive approach for cancer analysis.
- Despite two decades of research, clinical application for brain tumors remains limited.
- Challenges persist in translating promising liquid biopsy results into effective patient care.
Purpose of the Study:
- To review the promises, developments, and challenges of liquid biopsy for brain tumors.
- To highlight the need for standardized biomarkers and methods.
- To discuss the potential of liquid biopsy in cancer diagnosis, prognosis, monitoring, and therapy.
Main Methods:
- Literature review focusing on liquid biopsy techniques for brain tumors.
- Analysis of circulating tumor cells, cell-free nucleic acids, extracellular vesicles, and miRNA.
- Discussion of current challenges and future directions.
Main Results:
- Liquid biopsy holds potential for personalized cancer analysis.
- Key components include circulating tumor cells, cell-free nucleic acids, extracellular vesicles, and miRNA.
- Significant hurdles exist in biomarker validation and standardization.
Conclusions:
- Establishing robust biomarkers and standards is crucial for clinical adoption.
- Liquid biopsy can potentially revolutionize brain tumor management.
- Further research is essential to overcome current limitations and improve patient outcomes.
